home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Harmony Biosciences Holdings, Inc. - Common Stock (NQ:HRMY)

36.80 -0.04 (-0.10%)

Streaming Delayed Price Updated: 9:59 AM EST, Jan 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Harmony Biosciences Holdings, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Quick Look At Reports From ServiceNow, Chipotle, And Harmony ↗

November 02, 2023

ServiceNow is a steady, reliable SaaS firm that continues to prove its value and growth potential to investors.

Via Talk Markets

NASDAQ:HRMY is an undervalued gem with solid fundamentals. ↗

November 01, 2023

For those who appreciate value investing, HARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY) is a compelling option with its solid fundamentals.

Via Chartmill

Harmony Biosciences (HRMY) Q3 2023 Earnings Call Transcript ↗

October 31, 2023

HRMY earnings call for the period ending September 30, 2023.

Via The Motley Fool

Topics Earnings

Arista Networks, JinkoSolar, Repligen, Shutterstock And Other Big Stocks Moving Higher On Tuesday ↗

October 31, 2023

U.S. stocks traded lower, with the Dow Jones falling more than 50 points on Tuesday. Here are some major stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Harmony Biosciences's Earnings Outlook ↗

October 30, 2023

Via Benzinga

Analyst Ratings for Harmony Biosciences ↗

October 16, 2023

Via Benzinga

In the world of growth stocks, NASDAQ:HRMY shines as a value proposition. ↗

October 12, 2023

NASDAQ:HRMY, a growth stock which is not overvalued.

Via Chartmill

Expert Ratings for Harmony Biosciences ↗

September 25, 2023

Via Benzinga

Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

October 31, 2023

Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian patent office for its patent application for...

Via Benzinga

Topics Intellectual Property

Harmony Biosciences Reports Strong Third Quarter 2023 Financial Results

October 31, 2023

From Harmony Biosciences

Via GlobeNewswire

9 Analysts Have This to Say About Harmony Biosciences ↗

September 07, 2023

Via Benzinga

Expert Ratings for Harmony Biosciences ↗

August 22, 2023

Via Benzinga

Why Harmony Biosciences Stock Is Trading Higher Today ↗

October 16, 2023

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) shares are trading higher on Monday as the stock rebounds after falling Friday on Phase 3 INTU

Via Benzinga

Nasdaq Down Over 1%; Wells Fargo Beats Expectations ↗

October 13, 2023

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 1% on Friday. The Dow traded down 0.02% to 33,622.97 while the NASDAQ fell 1.27% to 13,401.56. The S&P...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 13, 2023

Via Benzinga

Stocks Mixed Amid Earnings, Consumer Sentiment Data ↗

October 13, 2023

Stocks are mixed this afternoon, as investors unpack earnings reports from several bank giants as well as economic data.

Via Talk Markets

Why Shares of Harmony Bioscience Are Falling on Friday ↗

October 13, 2023

The company reported underwhelming phase 3 trial results for Pitolisant to treat idiopathic hypersomnia.

Via The Motley Fool

Why Belden Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

October 13, 2023

Gainers Sigma Additive Solutions, Inc. (NASDAQ: SASI) shares jumped 196% to $7.34 after the company announced the signing of a definitive agreement for the acquisition of NextTrip Holdings, Inc.

Via Benzinga

Crude Oil Rises Sharply; Citigroup Posts Upbeat Earnings ↗

October 13, 2023

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling over 1% on Friday. The Dow traded down 0.05% to 33,615.27 while the NASDAQ fell 1.22% to 13,409.29. The S&P 500 also...

Via Benzinga

Topics Stocks

Why Is Sleep Disorder Related Harmony Biosciences Stock Trading Lower Today? ↗

October 13, 2023

Harmony Biosciences Holdings Inc (NASDAQ: HRMY) announced topline results from the INTUNE Phase 3 study of pitolisant in patients with idiopathic hypersomnia (IH).

Via Benzinga

New Possibilities For Cannabinoid Treatments: Acquisition To Transform Neuropsychiatric Disorder Therapies ↗

October 11, 2023

Healthcare company Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) completed its previously announced acquisition of Zynerba Pharmaceuticals, Inc.

Via Benzinga

2 Magnificent Growth Stocks to Buy Right Now ↗

October 04, 2023

These two biotech stocks could be big winners for patient investors.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023 ↗

September 25, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2023 ↗

September 07, 2023

Via Benzinga

ZYNERBA PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Zynerba Pharmaceuticals, Inc. - ZYNE

August 17, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

NASDAQ: HRMY Investor Alert: Investigation over Potential Wrongdoing at Harmony Biosciences Holdings, Inc. ↗

August 17, 2023

San Diego, CA -- (SBWIRE) -- 08/17/2023 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at Harmony Biosciences Holdings, Inc.

Via SBWire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Zynerba Pharmaceuticals, Inc. (Nasdaq - ZYNE), Chindata Group Holdings Limited (Nasdaq - CD), Capri Holdings Limited (NYSE – CPRI), Avid® (Nasdaq - AVID)

August 14, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

Crude Oil Down 1%; Zynerba Pharmaceuticals Shares Spike Higher ↗

August 14, 2023

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 90 points on Monday. The Dow traded down 0.14% to 35,232.62 while the NASDAQ rose 0.66% to 13,735.42. The...

Via Benzinga

Topics Stocks

Why Is Zynerba Pharmaceuticals (ZYNE) Stock Up 270% Today? ↗

August 14, 2023

With Harmony Biosciences acquiring Zynerba Pharmaceuticals, ZYNE stock jumped on both the buyout and the underlying therapeutic implications.

Via InvestorPlace

Health Care Company Harmony Biosciences Announces Acquisition of Zynerba Pharmaceuticals ↗

August 14, 2023

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com